Notice: Undefined index: HTTP_ACCEPT_LANGUAGE in C:\inetpub\wwwroot\technology_detail.php on line 331
 Technology Detail


The Office of Technology Licensing was established in 1970 to transfer technologies developed at Stanford. Find out more about OTL's history, mission, staff, and statistics.

Login to TechFinder » 

Recombinase-Mediated Site Specific Integration ("Wildtype" recombinases)


Stanford Reference:

97-168


Abstract


Researchers in Michele Calos' lab have developed a patented method to provide site-specific integration of genes of interest into the chromosomes of target cells. The method uses a recombinase enzyme to mediate integration of incoming DNA into inserted or pre-existing target sites in the chromosomes. The integration frequency in human and mouse cells is higher than that of homologous recombination or random integration. Integration may occur predominantly at a low number of positions. The method applies to various higher eukaryotic species and can be used in combination with most gene delivery methods.

Applications


  • Construction of transgenic animals and plants
  • Rapid construction of cell lines for protein production
  • Modification of cells, tissues, and organs, for a variety of uses

Advantages


  • If the method is applied to pre-existing target sites in the genome, it is not necessary to first insert the target site.
  • Integration frequency is higher than the frequency of homologous recombination or random integration.
  • Because integration is carried out by a recombinase enzyme with defined specificity, integration is more site specific than the random integration typical of most current gene introduction methods.

Publications



Calos Lab Web Page


www.stanford.edu/~calos/

Innovators & Portfolio



Patent Status



Date Released

 5/11/2000
 

Licensing Contact


Ximena Ares, Licensing Associate
650-724-0960 (Direct)
Login to Request Information

[-] Map/Timeline

78-017 Monoclonal Antibodies: 11-6 anti-Ig-5b, 11-5 anti-I-A (2), 11-4 anti-H-2Kk, 11-3 anti-I-A917), 10-4 anti-Ig-5a, H-12 anti-THY 1.2
82-008 A Monoclonal Antibody Specific For Mouse Granulocytes
82-010 A Monoclonal Antibody Specific for the B-220 Surface Glycoprotein in Mouse (RA3-3A1)

more technologies »

Related Keywords


therapeutic: gene therapy   research tool   therapeutic   
 

   

  

Also of Interest...
78-017 Monoclonal Antibodies: 11-6 anti-Ig-5b, 11-5 anti-I-A (2), 11-4 anti-H-2Kk, 11-3 anti-I-A917), 10-4 anti-Ig-5a, H-12 anti-THY 1.2
82-008 A Monoclonal Antibody Specific For Mouse Granulocytes
82-010 A Monoclonal Antibody Specific for the B-220 Surface Glycoprotein in Mouse (RA3-3A1)

Recently Viewed...
S97-168 Recombinase-Mediated Site Specific Integration ("Wildtype" recombinases)